<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Somatic cell hybrids, obtained after fusion of translocation (11;22)-positive Ewing <z:hpo ids='HP_0100242'>sarcoma</z:hpo> cells and Chinese hamster fibroblasts, were assayed for the presence of immunoglobulin C lambda, Philadelphia chromosome breakpoint cluster region, and c-<z:chebi fb="70" ids="30585">sis</z:chebi> oncogene sequences </plain></SENT>
<SENT sid="1" pm="."><plain>It was found that c-<z:chebi fb="70" ids="30585">sis</z:chebi> was translocated from chromosome 22 to chromosome 11 in the Ewing <z:hpo ids='HP_0100242'>sarcoma</z:hpo> cells used, indicating that the breakpoint must be proximal to this locus </plain></SENT>
<SENT sid="2" pm="."><plain>Moreover, we found that the chromosome 22-linked C lambda and breakpoint cluster region sequences are not translocated </plain></SENT>
<SENT sid="3" pm="."><plain>This result confirms an earlier cytogenetic observation that the Ewing <z:hpo ids='HP_0100242'>sarcoma</z:hpo>-associated breakpoint in chromosome 22 is distal to those observed in translocation (8;22)-positive Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and in <z:e sem="disease" ids="C0856536" disease_type="Neoplastic Process" abbrv="">Philadelphia chromosome-positive</z:e> <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>